Takada J, Ishii S, Ohta T, Koshiba H, Matsuyama T, Usui M, Yamawaki S, Mori M
Department of Orthopaedic Surgery, Sapporo Medical College, Japan.
Virchows Arch A Pathol Anat Histopathol. 1992;420(6):507-11. doi: 10.1007/BF01600255.
A novel monoclonal antibody against human osteocalcin, recently established in our laboratory, was shown by immunoblotting and immunohistochemistry to react specifically with human osteoblasts. In the present study, the antibody was applied to the immunohistochemical diagnosis of human bone tumours, especially osteoblastic tumours. The antibody reacted with all 27 osteosarcomas. No positive reaction was found either in chondrosarcoma, giant cell tumours of bone, soft tissue tumours or epithelial tumours. A positive reaction was found preferentially in the cytoplasm of most of the osteosarcoma cells, but not in the extracellular matrix. Since the antibody reacted with formalin-fixed and paraffin-embedded tissues, it will be a useful tool for routine immunohistochemical diagnosis of osteoblastic lesions.
我们实验室最近制备的一种新型抗人骨钙素单克隆抗体,经免疫印迹和免疫组织化学证实可与人成骨细胞特异性反应。在本研究中,该抗体被应用于人类骨肿瘤尤其是成骨细胞瘤的免疫组织化学诊断。该抗体与所有27例骨肉瘤均发生反应。在软骨肉瘤、骨巨细胞瘤、软组织肿瘤或上皮性肿瘤中均未发现阳性反应。在大多数骨肉瘤细胞的细胞质中优先发现阳性反应,但在细胞外基质中未发现。由于该抗体可与福尔马林固定、石蜡包埋的组织发生反应,它将成为成骨细胞性病变常规免疫组织化学诊断的有用工具。